CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 11 No. 6
 

Guidelines for the Early Referral of Patients to Cancer Specialists

Bernard Gardner, MD
Professor of Surgery, Director of Surgical Education, UMDNJ-New Jersey Medical School Newark, New Jersey
Kirby I. Bland, MD
J. Murray Beardsley Professor, Brown University School of Medicine, and Chairman, Department of Surgery, Rhode Island Hospital, Providence, Rhode Island

| June 1, 1997

Several years ago, during Dr. Gardner's tenure as President of the Society of Surgical Oncology (SSO), the SSO's Executive Council agreed to the development of practice guidelines for early referral of potential cancer patients. This move was stimulated by the spread of managed care and the fear that an emphasis on cost containment might establish a barrier to early referral. We had all witnessed the disastrous consequences of delayed treatment of cancer patients and were concerned that these influences might discourage the use of advanced diagnostic techniques, such as MRI, CT, biopsy, and endoscopy, which are vital in the diagnosis of soft-tissue sarcomas, abdominal or gastrointestinal cancer, and breast and lung cancer.

We recognized that medicine is not an exact science. Clear choices of appropriate treatments are not always obvious, and considerable disagreements may arise among physicians of different or even the same specialty with regard to treatment algorithms. We do strongly believe, however, that the diagnosis and management of complicated problems in malignant disease, done correctly the first time, is both good medical practice and cost efficient.

We did not have treatment protocols as our specific aim, and therefore, the extensive development cycles required to produce evidence-based practice guidelines were unnecessary. We felt that we were free to use the broad clinical experience residing in the membership of the Society to produce guidelines for early referral that were not likely to result in significant controversy.

The task of overseeing the development of these practice guidelines was given to Dr. Alfred Cohen, Chairman of the Clinical Affairs Committee and, with mutual consultation, we put together the site committees listed in Table 1.

After extensive work and rewriting, a series of practice guidelines were produced that cover all of the main sites that surgical oncologists diagnose and treat. Some of those guidelines are presented in this issue of oncology and others will appear in future issues.

We realize that patients are not all the same. Differences in presentation may lead to variations in treatment approach. The purpose of these guidelines is to encourage the early involvement of cancer specialists in the evaluation of patients who may have the disease. The guidelines are designed to facilitate a sharing of the burden of responsibility of early diagnosis between the family physician and specialist. We recognize that the intricate relationship between doctor and patient may modify the approach in some cases.

Our Society does not suggest that these guidelines replace good medical judgment. That always comes first. We do believe that family physicians, as well as directors of health maintenance organizations, will appreciate the provision of these guidelines as a reference for better patient care.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy